Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the prostate cancer prevention trial.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  American Journal of Epidemiology

• Publication date

  2011-06-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/aje/kwq493PMID 21540324PMCID PMC3276227
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.

  2010cited by this paper
• Alcohol consumption, finasteride, and prostate cancer risk

  2009cited by this paper
• Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.

  2008cited by this paper
• Cigarette smoking and prostate cancer-specific mortality following diagnosis in middle-aged men

  2008cited by this paper
• Inflammation in prostate carcinogenesis

  2007cited by this paper
• Alcohol consumption, smoking, and other risk factors and prostate cancer in a large health plan cohort in California (United States)

  2005cited by this paper
• Easy SAS calculations for risk or prevalence ratios and differences.

  2005cited by this paper
• Fingerprinting the diseased prostate: Associations between BPH and prostate cancer

  2004cited by this paper
• The influence of finasteride on the development of prostate cancer.

  2003cited by this paper
• Prostate carcinoma risk subsequent to diagnosis of benign prostatic hyperplasia

  2003influential reference
• Estimating the relative risk in cohort studies and clinical trials of common outcomes.

  2003cited by this paper
• Prostate-specific antigen best practice policy--part I: early detection and diagnosis of prostate cancer.

  2001cited by this paper
• Pathology of benign prostatic hyperplasia

  2000cited by this paper
• New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia.

  1999cited by this paper
• The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia

  1998cited by this paper
• High rates of prostate-specific antigen testing in men with evidence of benign prostatic hyperplasia.

  1998cited by this paper
• The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group.

  1998cited by this paper
• The impact of systematic prostate biopsy on prostate cancer incidence in men with symptomatic benign prostatic hyperplasia undergoing transurethral resection of the prostate.

  1997cited by this paper
• Interpreting results of prostate-specific antigen testing for early detection of prostate cancer

  1996cited by this paper
• Serum prostate specific antigen levels after transurethral resection of prostate: a longitudinal characterization in men with benign prostatic hyperplasia.

  1996cited by this paper
• Role of androgen in prostate growth and regression: Stromal‐epithelial interaction

  1996cited by this paper
• Do prostate size and urinary flow rates predict health care-seeking behavior for urinary symptoms in men?

  1995cited by this paper
• The influence of prostate size on cancer detection.

  1995cited by this paper
• A population-based study of health care-seeking behavior for treatment of urinary symptoms. The Olmsted County Study of Urinary Symptoms and Health Status Among Men.

  1993cited by this paper
• The relation of surgery for prostatic hypertrophy to carcinoma of the prostate.

  1993cited by this paper
• The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association.

  1992influential reference
• The association of benign prostatic hyperplasia and cancer of the prostate

  1992cited by this paper
• Natural history of benign prostatic hyperplasia (BPH)

  1989cited by this paper
• Zonal Distribution of Prostatic Adenocarcinoma: Correlation with Histologic Pattern and Direction of Spread

  1988cited by this paper
• Latent prostatic cancer in a consecutive autopsy series.

  1980cited by this paper
• Incidental carcinoma of the prostate: a review of the literature and critical reappraisal of classification.

  1980cited by this paper
• Latent carcinoma of prostate at autopsy in seven areas. Collaborative study organized by the International Agency for Research on Cancer, Lyons, France

  1977cited by this paper
• Cancer of the prostate among men with benign prostatic hyperplasia.

  1974cited by this paper
• Relation between benign prostatic hyperplasia and cancer of the prostate. A prospective and retrospective study.

  1974influential reference
• International Agency for Research on Cancer.

  1968cited by this paper
• The results of 1,694 consecutive simple perineal prostatectomies.

  1957cited by this paper
• Endocrine changes with prostatic carcinoma

  1957cited by this paper
• Occult carcinoma in clinically benign hypertrophy of the prostate; a pathological and clinical study.

  1952cited by this paper

• Feasibility of water vapor thermal therapy for treating lower urinary tract symptoms in men with localized prostate cancer on active surveillance: a case series.

  2026cites this paper
• Insights from computational studies about structural determinants of steroidal inhibitors in 5-alpha-reductase type II

  2025cites this paper
• Hiperplasia benigna de próstata

  2025cites this paper
• Causal relationship between prostatic diseases and prostate cancer: a mendelian randomization study

  2024cites this paper
• Causal relationship between benign prostatic hyperplasia and prostate cancer: a bidirectional Mendelian randomization analysis.

  2024cites this paper
• Health Professionals’ Perceptions about Prostate Cancer—A Focus Group Study

  2024cites this paper
• Detection of Prostate Cancer and Benign Prostatic Hyperplasia Using Prostate-Specific Antigen Testing: A Review of Clinical Research Studies

  2024cites this paper
• MRI of Benign Prostatic Hyperplasia: Important Pre- and Posttherapeutic Considerations.

  2023cites this paper
• Unveiling Disrupted Lipid Metabolism in Benign Prostate Hyperplasia, Prostate Cancer, and Metastatic Patients: Insights from a Colombian Nested Case–Control Study

  2023cites this paper
• Low-Value Prostate Cancer Screening Among Young Men With Private Insurance

  2023cites this paper
• DNA methylation biomarkers distinguishing early-stage prostate cancer from benign prostatic hyperplasia

  2023cites this paper
• Screening for prostate cancer: protocol for updating multiple systematic reviews to inform a Canadian Task Force on Preventive Health Care guideline update

  2022cites this paper
• Urinary symptoms and prostate cancer—the misconception that may be preventing earlier presentation and better survival outcomes

  2022cites this paper
• Prostate cancer screening in hospitalized patients: Results from the Nationwide Inpatient Sample

  2021cites this paper
• Benign prostate hyperplasia as a potential protective factor against prostate cancer: Insights from a magnetic resonance imaging study of compositional characteristics

  2021influential citation
• Development and validation of a predictive model for determining clinically significant prostate cancer in men with negative magnetic resonance imaging after transrectal ultrasound‐guided prostate biopsy

  2021cites this paper
• Impact of median lobe on urinary function after robotic prostatectomy

  2021cites this paper
• Identifying Prostate Cancer Among Men with Lower Urinary Tract Symptoms

  2021cites this paper
• Herb-target virtual screening and network pharmacology for prediction of molecular mechanism of Danggui Beimu Kushen Wan for prostate cancer

  2021cites this paper
• Chronic exposure to microcystin-LR increases the risk of prostate cancer and induces malignant transformation of human prostate epithelial cells.

  2021cites this paper
• Correlation between Prostatitis, Benign Prostatic Hyperplasia and Prostate Cancer: A systematic review and Meta-analysis

  2020cites this paper
• Subsequent risk of acute urinary retention and androgen deprivation therapy in patients with prostate cancer

  2020cites this paper
• Impact of Benign Prostatic Hyperplasia and/or Prostatitis on the Risk of Prostate Cancer in Korean Patients

  2020cites this paper
• Biomarkers That Differentiate Benign Prostatic Hyperplasia from Prostate Cancer: A Literature Review

  2020cites this paper
• Phenotypic switching and prostate diseases: a model proposing a causal link between benign prostatic hyperplasia and prostate cancer

  2020cites this paper
• Role of Prostate Specific Antijen in Prostatic Adenocarcinoma Detection in Patients with Benign Prostate Hyperplasia and Were Placed Urethral Catheter After Acute Urinary Retention

  2020cites this paper
• Prostat Spesifik Antijenin Akut Üriner Retansiyon Sonrası Üretral Kateter Yerleştirilen ve Benign Prostat Hiperplazisi Olan Hastalarda Prostat Adenokarsinomu Saptamadaki Rolü

  2020cites this paper
• Prostate resected weight and postoperative prostate cancer incidence after transurethral resection of the prostate

  2019cites this paper
• Robot-assisted pelvic lymphadenectomy for prostate cancer . Potentially advantageous in the elderly ?

  2019cites this paper
• Real-World Evidence of Prostatic Urethral Lift Confirms Pivotal Clinical Study Results: 2-Year Outcomes of a Retrospective Multicenter Study

  2019cites this paper
• Lower urinary tract symptoms (LUTS) are not associated with an increased risk of prostate cancer in men 50–69 years with PSA ≥3 ng/ml

  2019cites this paper
• Serum Steroid Ratio Profiles in Prostate Cancer: A New Diagnostic Tool Toward a Personalized Medicine Approach

  2018cites this paper
• Transcriptomic analysis of prostate cancer progression

  2018cites this paper
• Over-Expression of Aryl Hydrocarbon Receptor (AhR) Enhances Src Kinase Activity to Functionally Induce AR Signaling and Promote Prostate Cancer Progression

  2018cites this paper
• Modern-day prostate cancer is not meaningfully associated with lower urinary tract symptoms: Analysis of a propensity score-matched cohort.

  2017cites this paper
• The Role of Nuclear Factor Kappa B in Benign Prostatic Hyperplasia

  2016cites this paper
• Disorder, Promiscuous Interactions, and Stochasticity Regulate State Switching in the Unstable Prostate

  2016cites this paper
• Discriminación entre hiperplasia prostática benigna y cáncer de próstata mediante el uso de PSA index en consulta externa de urología

  2016cites this paper
• Benign Prostatic Hyperplasia and the Risk of Prostate Cancer and Bladder Cancer

  2016cites this paper
• NF‐κB and androgen receptor variant expression correlate with human BPH progression

  2016cites this paper
• Role of Macrophages in the Development of Castration-Resistant Prostate Cancer

  2016cites this paper
• Interactions between benign prostatic hyperplasia (BPH) and prostate cancer in large prostates: a retrospective data review

  2015cites this paper
• Triptorelin in the Relief of Lower Urinary Tract Symptoms in Advanced Prostate Cancer Patients: The RESULT Study

  2015cites this paper
• Anoctamin 1 (TMEM16A) is essential for testosterone-induced prostate hyperplasia

  2015cites this paper
• Exploring the experience of prostate surgery among male patients with benign prostatic hyperplasia: a qualitative content analysis

  2015cites this paper
• Efecto de la hormona de crecimiento sobre la proliferación y supervivencia de la línea celular de cáncer de próstata LNCaP

  2015cites this paper
• Antioxidant Function of Pigment Epithelium Derived Factor in Adipose Tissue, the Prostate, and Prostate Cancer

  2015cites this paper
• Tumor targeting with a 99mTc-labeled AS1411 aptamer in prostate tumor cells

  2015cites this paper
• Benign prostatic hyperplasia and prostate cancer differentiation via platelet to lymphocyte ratio

  2015cites this paper
• BPH: a tell-tale sign of prostate cancer? Results from the Prostate Cancer and Environment Study (PROtEuS)

  2015cites this paper
• Platinum Priority – Review – Benign Prostatic Hyperplasia

  2014cites this paper
• Facteurs de risques génétiques associés à la patho-biologie du vieillissement prostatique

  2014cites this paper
• Functional characterisation of phosphodiesterase 4D7 in prostate cancer

  2014cites this paper
• BPH and prostate cancer risk

  2014cites this paper
• Systematic Review and Meta-analysis of Candidate Gene Association Studies of Lower Urinary Tract Symptoms in Men

  2014cites this paper
• Differential gene expression analysis and genetic association studies in benign and malignant prostate tissues

  2014cites this paper
• Addressing the contribution of previously described genetic and epidemiological risk factors associated with increased prostate cancer risk and aggressive disease within men from South Africa

  2013cites this paper
• The effect of benign lower urinary tract symptoms on subsequent prostate cancer testing and diagnosis.

  2013cites this paper
• The link between benign prostatic hyperplasia and prostate cancer

  2013cites this paper
• Experience of transurethral resection of the prostate: a qualitative study

  2013cites this paper
• Should modest elevations in prostate-specific antigen, International Prostate Symptom Score, or their rates of increase over time be used as surrogate measures of incident benign prostatic hyperplasia?

  2013cites this paper
• Stromal Response to Prostate Cancer: Nanotechnology-Based Detection of Thioredoxin-Interacting Protein Partners Distinguishes Prostate Cancer Associated Stroma from That of Benign Prostatic Hyperplasia

  2013cites this paper
• High‐grade prostate cancer and biochemical recurrence after radical prostatectomy among men using 5α‐reductase inhibitors and alpha‐blockers

  2013cites this paper
• Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk

  2013cites this paper
• Does benign prostatic hyperplasia treatment with alpha-blockers affect prostate cancer risk?

  2013cites this paper
• Lower urinary tract symptoms, benign prostatic hyperplasia, and prostate cancer: seek and ye shall find.

  2013cites this paper
• Why are diabetics at reduced risk for prostate cancer? A review of the epidemiologic evidence.

  2012cites this paper
• Comprehensive Population-Specific Marker Panel for Early Prostate Cancer Diagnostics and Risk Assessment

  2012cites this paper
• Indications for and use of nonsteroidal antiinflammatory drugs and the risk of incident, symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial.

  2012cites this paper
• Reply from Authors re: Ryan P. Kopp, Stephen J. Freedland, J. Kellogg Parsons. Associations of Benign Prostatic Hyperplasia With Prostate Cancer: The Debate Continues. Eur Urol 2011;60:699–700

  2011cites this paper
• Associations of benign prostatic hyperplasia with prostate cancer: the debate continues.

  2011cites this paper